CD8A and neoplasm: G47Δ-mIL12 treatment induced both local and systemic effects, including increased CD8+ TILs and reduced MDSCs in both treated and untreated tumors, increased DCs in the spleen, and decreased tumor vascularity and increased CXCL10 [43].